[HTML][HTML] Estimation of liver fat by FibroScan in patients with nonalcoholic fatty liver disease
R Shrestha, KC Sudhamshu, P Thapa, A Pokharel… - Cureus, 2021 - ncbi.nlm.nih.gov
Background Assessment of nonalcoholic fatty liver disease (NAFLD) includes estimation of
liver fat (steatosis). Controlled attenuation parameter (CAP) value obtained by …
liver fat (steatosis). Controlled attenuation parameter (CAP) value obtained by …
Body mass index–based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease
Abstract Background and Aim In patients with liver disease, etiology and body mass index
(BMI) affects controlled attenuation parameter (CAP) assessment using FibroScan. We …
(BMI) affects controlled attenuation parameter (CAP) assessment using FibroScan. We …
Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population
WK Chan, NR Nik Mustapha… - United European …, 2017 - journals.sagepub.com
Background The FibroScan® XL probe reduces failure of liver stiffness measurement (LSM)
and unreliable results in obese patients. Objective The objective of this article is to evaluate …
and unreliable results in obese patients. Objective The objective of this article is to evaluate …
Quantitative ultrasound assessment of hepatic steatosis
A Kaliaev, W Chavez, J Soto, F Huda, H Xie… - Journal of Clinical and …, 2022 - Elsevier
Background/Aims Non-alcoholic fatty liver disease (NAFLD) is widespread chronic disease
of the live in humans with the prevalence of 30% of the United States population. 1, 2 The …
of the live in humans with the prevalence of 30% of the United States population. 1, 2 The …
[HTML][HTML] Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease
M Hernández-Conde, E Llop, CF Carrillo… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Obesity is a risk factor for non-alcoholic fatty liver disease (NAFLD),
although obese patients with NAFLD do not always develop significant fibrosis. The …
although obese patients with NAFLD do not always develop significant fibrosis. The …
Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique
SC Lin, E Heba, T Wolfson, B Ang, A Gamst… - Clinical …, 2015 - Elsevier
Background & Aims Liver biopsy analysis is the standard method used to diagnose
nonalcoholic fatty liver disease (NAFLD). Advanced magnetic resonance imaging is a …
nonalcoholic fatty liver disease (NAFLD). Advanced magnetic resonance imaging is a …
Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver …
PJ Eddowes, M Sasso, M Allison, E Tsochatzis… - Gastroenterology, 2019 - Elsevier
Background & Aims We estimated the accuracy of FibroScan vibration-controlled transient
elastography controlled attenuation parameter (CAP) and liver stiffness measurement …
elastography controlled attenuation parameter (CAP) and liver stiffness measurement …
Diagnostic performance of 9 quantitative ultrasound parameters for detection and classification of hepatic steatosis in nonalcoholic fatty liver disease
Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease worldwide. Quantitative ultrasound (QUS) parameters based on radiofrequency raw …
disease worldwide. Quantitative ultrasound (QUS) parameters based on radiofrequency raw …
Volumetric liver fat fraction determines grade of steatosis more accurately than controlled attenuation parameter in patients with nonalcoholic fatty liver disease
S Harry, LL Lai, NRN Mustapha, YFA Aziz… - Clinical …, 2020 - Elsevier
Background & Aims HepaFat-Scan is a magnetic resonance imaging-based method for
quantification of hepatic steatosis by volumetric liver fat fraction (VLFF) measurement. We …
quantification of hepatic steatosis by volumetric liver fat fraction (VLFF) measurement. We …
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease
WK Chan, NR Nik Mustapha… - … of gastroenterology and …, 2014 - Wiley Online Library
Abstract Background and Aim Controlled attenuation parameter (CAP) has been suggested
as a noninvasive method for detection and quantification of hepatic steatosis. We aim to …
as a noninvasive method for detection and quantification of hepatic steatosis. We aim to …